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Inhibition of Putative Hyalurosome Platform
in Keratinocytes as a Mechanism for
Corticosteroid-Induced Epidermal Atrophy
Laurent Barnes1, Fre´de´rique Ino1, Fabienne Jaunin1, Jean-Hilaire Saurat2 and Gu¨rkan Kaya1
The main limitation of using topical corticosteroids in dermatology is their atrophic effects on the skin. We have
previously proposed a molecular platform composed of CD44, EGFR, and hyaluronate synthase (HAS) that is
functionally defective in dermatoporosis, a chronic cutaneous insufficiency/fragility syndrome. In this study, we
explored the molecular mechanisms of the skin atrophy induced by corticosteroids. We observed an important
skin atrophy and a significant decrease of hyaluronic acid (HA), its main cell surface receptor CD44, and F-actin in
mouse skin treated with topical clobetasol propionate (CP). Human keratinocytes exposed to CP showed
an impaired HA secretion and diminished expression of CD44 and HAS3. CP also abolished filopodia
of keratinocytes exposed to CP together with a redistribution of CD44 and F-actin depolymerization. We
also show that HA fragments of intermediary size (HAFi) induced keratinocyte filopodia and protected them
against CP. Topical HAFi induced hyperplasia in mouse epidermis and prevented CP-induced atrophy. Our results
suggest that a CD44/EGFR/HAS platform associated with F-actin and filopodia of keratinocytes is the target of
corticosteroids for their atrophogenic effects. These observations may lead to the development of new treatment
and prevention strategies for corticosteroid-induced skin atrophy.
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INTRODUCTION
With the increase of lifespan and prolonged sun exposure,
skin aging, more than just causing cosmetic troubles, is
becoming a matter of greater importance, as its final stage in
the elderly may be a loss of skin functions (Rabe et al., 2006;
Farage et al., 2009). This new concept was described under
the notion of chronic cutaneous insufficiency/fragility
syndrome named ‘‘dermatoporosis’’ (Kaya and Saurat, 2007;
Saurat, 2007; Kaya, 2008; Kaya et al., 2008). The skin affected
by dermatoporosis becomes progressively atrophic and loses
its mechanical properties. An impaired production of the
extracellular matrix (ECM) components such as hyaluronic
acid (HA), collagen, and elastic fibers contributes to
dermatoporosis. Besides intrinsic aging and photoaging
(Farage et al., 2008), topical and systemic corticosteroid
treatments have been proposed as strong inducers of
premature signs of dermatoporosis (Schoepe et al., 2006).
HA, the major polysaccharide of the ECM, is crucial for skin
hydration and mechanical properties, and possesses several
biological activities (Stern and Maibach, 2008). HA
contributes to molecule trafficking (Mahoney et al., 2001;
Lee et al., 2010) and regulates cell proliferation, tissue
remodeling, healing, and inflammation (Karvinen et al.,
2003; Matsumoto et al., 2009; Monslow et al., 2009; Chow
et al., 2010). CD44, the principal cell surface receptor of HA,
is involved in these biological activities (Kaya et al., 1997,
2006).
The function of HA in the epidermis is unclear, even if HA
has been detected in the epidermal interkeratinocyte spaces
(Tammi et al., 2005; Barnes et al., 2012). Mammalian HA
synthesis is under the control of three enzymes, HA synthase 1
(HAS1), HAS2, and HAS3 (Tien and Spicer, 2005; Spicer
et al., 2002). ILs and growth factors such as keratinocyte
growth factor and EGF positively regulate HA synthesis
(Campo et al., 2006; Chow et al., 2010). The expression of
HAS3 has also been shown to be increased in the inflamed
epidermis, suggesting a role of HA metabolism in the
epidermal homeostasis (Mack et al., 2011; Barnes et al.,
2012). HA secretion takes place in cellular structures known
as filopodia, indicating that filopodia and HA secretion are
closely associated (Rilla et al., 2005; Kultti et al., 2006; Rilla
et al., 2008). Filopodia are rich in F-actin fibers, involved in
cell adhesion and motility, and are very sensitive to EGFs
(Lidke et al., 2005; Dise et al., 2008). Filopodia may then be a
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key cell structure for epidermal homeostasis. Our previous
studies showed that topical application of intermediate-sized
HA fragments (HAFi, 50–400 kDa) induced an epidermal
hyperplasia characterized by an increased expression of
CD44, heparin-binding EGF (HB-EGF), and HA (Kaya et al.,
2005; Kaya et al., 2006; Barnes et al., 2010). We thus
hypothesize that hyalurosome, a molecular platform that we
have recently proposed (Barnes et al., 2010), may have a
fundamental role in the regulation of epidermal homeostasis.
To elucidate the role of HA in epidermal homeostasis, we
topically treated SKH1 hairless mice with clobetasol propio-
nate (CP), a potent atrophogenic corticosteroid, and further
explored whether HAFi was able to prevent the CP-induced
epidermal atrophy.
RESULTS
Topical CP induces a severe atrophy in SKH1 hairless mice,
which can be antagonized by HAFi
SKH1 hairless mice were treated for 6 days with two daily
applications of CP 0.05%, HAFi 2%, and the combination of
CP 0.05%/HAFi 2% on their back skin (short protocol). CP
induced a fast and strong skin atrophy revealed by a
transparent aspect of the skin. Microscopic analysis showed
a severe epidermal atrophy (Figure 1a and b). The dermis was
a
c
bControl
Control
Control
CD44
HA
Ki67
6.1±0.7
F-actin
+ CP 0.05%
CP 0.05%
+ HAFi 2%
HAFi 2%
+ CP 0.05%
+ HAFi 2%
CP 0.05% + HAFi 2%
60
P<0.0001
P<0.05 between each pair
μm
50
40
30
20
10
0
Epidermal thickness
CP 0.05%
CP 0.05% + HAFi 2%
HAFi 2%
2.2±1.4* 6.2±0.8 4.1±1.1**
Figure 1. The effect of clobetasol propionate (CP) and intermediate-sized hyaluronic acid fragments (HAFi) on mouse epidermis. (a) Histological sections of mice
treated with excipient, CP 0.05%, HAFi 2%, and CP 0.05%þHAFi 2% were stained with hematoxylin and eosin. (b) Epidermal thickness measurement values
were obtained from 10 measurements per microscopic field and three microscopic fields per mouse; 6 mice were used per point, giving a total of 180
measurements by condition. The central dot represents the average thickness, the boxes show 75% of values, and the bar indicates the maximum and minimum
values. The P-value was calculated with the analysis of variance (ANOVA) method followed by Newman–Keuls post hoc test to calculate P-values between each
group. (c) CD44, HA, Ki67, and F-actin staining (blue indicates 4’,6-diamidino-2-phenylindole dihydrochloride (DAPI) DNA counterstaining). Quantification of the
number of Ki67-positive cells standardized to the dermo–epidermal junction length are given with SD; * indicates value with Po0.05 compared with control, and
** indicates value with control and CP 0.05%. Scale bar¼ 52mm.
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also significantly atrophic with B50% loss of thickness (data
not shown). Other topical corticosteroids also induced similar
skin atrophy (data not shown). Topical treatment with HAFi
alone induced an epidermal hyperplasia, confirming the
biological activities of HAFi previously described (Kaya
et al., 2006). When HAFi was combined with CP, the
epidermal atrophy was significantly less severe than with CP
alone. However, HAFi had no effect on the dermal atrophy.
To identify whether the HA fragment size was important for
their anti-atrophic activity, we tried small HA fragments
(HAFs, average molecular size¼11 kDa) and large HA frag-
ments (HAFl, average molecular size¼ 1,149 kDa). The HAFs
could not prevent the CP-induced atrophy (data not shown).
No dermal atrophy was observed when CP was mixed with
HAFl, probably because of the reduced skin penetration
caused by the high density of the solution. We then treated
SKH1 hairless mice for 18 days sequentially by one CP topical
application in the morning and one HAFi or HAFl application
in the afternoon (long protocol) (Supplementary Figure S1
online). HAFi still prevented the epidermal atrophy and also
induced an epidermal hyperplasia when used alone, whereas
HAFl neither induced hyperplasia nor prevented the
CP-induced epidermal atrophy.
We then stained skin sections of mice of the short protocol
for Ki67, CD44, and a-actin (Figure 1c). Ki67 staining showed
a negative impact of CP, whereas HAFi had an opposite effect
in agreement with its prohyperplasic activity. In mice treated
with both HAFi and CP, the CP-induced proliferation inhibi-
tion was prevented. CD44 and HA were undetectable in the
epidermis of mice treated with CP, whereas in mice treated
with CP and HAFi, HA and CD44 signals were still visible,
indicating that HAFi counteracted their CP-induced depletion.
We also explored the epidermal F-actin network. CP alone
strongly affected the epidermal F-actin cytoskeleton, whereas
it appeared physiological in mice treated with CP and HAFi
(Figure 1c, Supplementary Figure S3 online). We also checked
keratin 1 and filaggrin expressions, but only a thinning
compatible with the atrophy was observed. No induction of
apoptosis was observed with a TUNEL staining
(Supplementary Figure S2 online).
CD44 and HAS3 located in filopodia are the targets of CP
As filopodial protrusions were previously described to be
highly dependent on HAS activity (Kultti et al., 2006;
Rilla et al., 2008), we investigated the effects of CP and
4-methylumbelliferone (4-MU, an inhibitor of HAS activity) on
filopodia in a human immortalized keratinocyte line
(Steenbergen et al., 1996). After only 1 hour, filopodial
density and length were reduced by 4-MU in a dose-
dependent manner and cells tended to form clusters, as
shown by a fluorescent a-phalloidin staining of F-actin
(Figure 2a). CP had similar effects on keratinocytes
(Figure 2b). Filopodia abolishment may likely be caused by
a depolymerization of F-actin into G-actin, as the short time
exposure to the substance rules out any genomic regulation.
G-actin was stained with fluorescent deoxyribonuclease I
conjugates (Figure 2c). In untreated cells, G-actin signal was
homogenous in the cytoplasm. In contrast, cytochalasin D
(CD, an inhibitor of F-actin polymerization) induced an
expected irregular G-actin staining pattern as CP or 4-MU,
indicating that both CP and 4-MU induced a rearrangement of
F-actin. The HA content in the supernatant of keratinocytes
exposed to CP or 4-MU also showed a dose-dependent
decrease, in agreement with the filopodial inhibition
(Figure 2d). A real-time quantitative PCR was further per-
formed on RNA extracts of cells exposed for 8 hours to CP or
4-MU (Figure 2e). The expression of CD44, HAS3, and EGFR
was downregulated proportionally to CP concentrations.
4-MU showed similar effects. In contrast, the expression of
HB-EGF increased slightly or stayed stable, whereas HAS2 and
hyaluronidase 2 RNAs were not detectable in any condition.
HAFi and CP have antagonist effects on filopodial growth
The molecular switch that induces filopodia by promoting
F-actin polymerization has been shown to be CDC42, a
protein of the Rho GTPase enzyme family that, when
activated, becomes GTP-bound (Bishop and Hall, 2000). As
the EGF is a known activator of CDC42 and filopodial growth
(Kurokawa et al., 2004; El-Sibai et al., 2007), we exposed for
1 hour subconfluent cultures of keratinocytes, cultivated
overnight in serum-free medium lacking EGF, to HAFi or
HB-EGF alone, or supplemented with CP or 4-MU (Figure 3).
Cells were then fixed and stained for F-actin and G-actin
(Figure 3a), and their filopodial frequency and size were
measured (Figure 3b). HB-EGF and HAFi both induced a fast
filopodial growth. However, when HB-EGF was used together
with 4-MU or CP, the filopodial activation was not observed.
G-actin staining showed that the inhibition of F-actin poly-
merization prevented filopodial growth. The EGFR activation
by HB-EGF was explored by western blotting using an anti-
body specific for the phosphorylated (Tyr 1068) form of EGFR
(Figure 3c). HAFi alone did not induce EGFR phosphorylation.
The expected EGFR phosphorylation induced by HB-EGF was
not affected by CP, 4-MU, or CD. We then investigated the
CDC42 activation in protein extracts of cells exposed for
6 minutes to HAFi and to HB-EGF with 4-MU, CP, or CD. In
agreement with their ability to induce filopodia, HAFi and HB-
EGF induced the activation of CDC42. In the presence of
4-MU, CDC42 activation by HB-EGF was reduced (4-MU
alone slightly reduced CDC42 activation, data not shown). In
contrast, CP and CD alone activated CDC42 and CP increased
the CDC42 activation by HB-EGF (Figure 3d). These results
suggest that CP and CD may have similar activity, and that
keratinocytes exposed to these molecules seem to compensate
the depolymerization of F-actin by increasing CDC42
activation.
HAFi protects keratinocyte filopodia from adverse effects of CP
and 4-MU
To see whether HAFi was able to antagonize the adverse
effects of CP on keratinocytes, we exposed human keratino-
cytes to the same concentrations of CP and 4-MU in the
presence of HAFi (100mg ml 1; Figure 4). After a 1-hour
exposure, F-actin staining showed preserved filopodia
(Figure 4a) with a persisting distribution of CD44v3 and HA
in filopodia (Figure 4b). The protection of filopodia by HAFi
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was still evident after 8 hours. HAFi also protected keratino-
cytes from the adverse effects of 4-MU after 1 and 8 hours of
exposure (Figure 4c).
The molecular weight of HAFi is crucial for its biological activity
To demonstrate the specificity of the biological activity of
HAFi molecular weight range (50–400 kDa), we also treated
SKH1 hairless mice with HAFs and HAFl. None of them
induced an epidermal hyperplasia (Figure 5d), nor were they
able to prevent CP-induced epidermal atrophy (data not
shown). In vitro experiments showed a higher ability of
keratinocytes to release or secrete HA in the supernatant after
a previous exposure to HAFi, compared with HAFs or HAFl
(Figure 5a). Keratinocytes exposed to HAFs or HAFl for
24 hours also failed to induce filopodia (Figure 6b and c),
correlating with the lack of their prohyperplastic effect
observed in vivo (Figure 5d). Thus, HAFi seems to have a
specific biological activity in the epidermis.
DISCUSSION
HA–CD44 interactions control epidermal homeostasis
Our results show that CP, one of the most potent proatrophic
topical corticosteroids (Pels et al., 2008), induces a drastic skin
atrophy. The disappearance of both CD44 and HA epidermal
staining indicates that CD44–HA interaction is mitigated by
CP in the atrophic epidermis. However, the generation of
CD44 interaction with exogenous HA brought by topical HAFi
prevented the effect of CP, indicating that CD44–HA depletion
is the cause of the epidermal atrophy, rather than the
consequence. Several lines of evidence suggest this interaction
as a kind of rheostat that controls the epidermal homeostasis.
CD44 has been described to have a role in cell motility, cell
proliferation, and inflammation (Teder et al., 2002; Turley
et al., 2002; Hamilton et al., 2007; Hatano et al., 2010). It is
also now well known that CD44–HA interactions can mod-
ulate mitogenic signals via intracellular pathways (Turley
et al., 2002; Hamilton et al., 2007; Bourguignon, 2008;
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Figure 2. The effect of 4-methylumbelliferone (4-MU) and clobetasol propionate (CP) on keratinocytes. (a, b) Filopodial quantification of a-phalloidin-rhodamine-
(red indicates F-actin) and 4’,6-diamidino-2-phenylindole dihydrochloride- (DAPI; blue indicates DNA) stained keratinocytes exposed for 1 hour to CP or 4-MU.
Lower panels represent the cumulative quantification of 10 cells, with±SEM shown. (c) G-actin staining with deoxyribonuclease I conjugates of keratinocytes
exposed for 1 hour to CP, cytochalasin D (CD), and 4-MU, with quantification of fluorescence intensity per image. Scale bar¼24mm. (d) Overnight accumulation
of hyaluronic acid (HA) in cell supernatants (n¼4). (e) Quantitative PCR performed on RNA extracts of cells exposed for 8 hours to CP or 4-MU (n¼3). The
P-value was calculated with the analysis of variance (ANOVA) method followed by Newman–Keuls post hoc test to calculate P-values between each group;
* indicates value with Po0.05 compared with control.
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Ohwada et al., 2008; Pure and Assoian, 2009). Our
observations may suggest an autocrine loop, formed by HA
secretion and CD44–HA interactions, which regulates epider-
mal homeostasis. The reported increased expression of HA
and CD44 in wound healing, inflamed epidermis, or in the
epidermis treated with retinoids would be the mark of
hyperproliferation (Kaya et al., 2005; Tammi et al., 2005;
Barnes et al., 2012).
Filopodia, the missing point that links HA metabolism and EGF
signaling
Our in vitro data showed that CP affected HA secretion and
the expression of F-actin and CD44, a pattern matching with
our in vivo observations (Figure 1). The direct effect of CP on
F-actin caused a filopodial collapse, leading to the inhibition
of HA secretion (Figure 2). CP is likely to block HA secretion
by inhibiting filopodia as a fast nongenomic mechanism.
However, a second late mechanism might implicate the
downregulation of has3, cd44, and EGFR genes, as their
expression was downregulated at 8 hours (Figure 2e).
Filopodia were also described as the platform where the
early EGFR signaling operates. Once activated by EGFs, the
EGFR has been described to migrate along the F-actin spine
of the filopodium from the top toward the base, where it is
supposed to initiate a cell signaling cascade (Lidke et al.,
2005; Wang et al., 2011). Therefore, the collapse of
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Figure 3. The intermediate-sized hyaluronic acid fragments (HAFi) and clobetasol propionate (CP) have antagonist effects on heparin-binding EGF
(HB-EGF)-induced actin polymerization in keratinocytes. (a) Filopodial induction by HAFi, HB-EGF, HB-EGFþ 4-MU, HB-EGFþCP, and HB-EGFþCD. 4-MU,
4-methylumbelliferone. a-Phalloidin-rhodamine of F-actin (red) or deoxyribonuclease I conjugate staining (green) of G-actin. Scale bar¼ 24mm. (b) Mean
size and frequency of filopodia per keratinocyte±SEM, based on 10 cells. (c) Phosphorylated EGFR (EGFR-P) western blot realized on keratinocyte protein extracts
exposed for 1 hour to HAFi, HB-EGF, CP, and cytochalasin D (CD). (d) Activated CDC42 measured in cell protein extracts of keratinocytes exposed for 6 minutes to
HAFi, HB-EGF, CP, and CD (n¼ 4). The P-values were calculated with the analysis of variance (ANOVA) method followed by Newman–Keuls post hoc
test to calculate P-values between each group; * indicates P-valueso0.05 compared with control, ** indicates P-valueso0.05 compared with control and HAFi,
and *** indicates P-values o0.05 compared with control, HAFi, and HB-EGF.
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filopodia might disrupt the early EGFR response and
impair epidermal homeostasis. CP had no effect on EGFR
phosphorylation (Figure 4). However, CP blocked the
filopodial induction by HB-EGF, and in presence of
CP cells appeared to be trying to compensate F-actin
depolymerization by an increased CDC42 activation. The
atrophogenic activity of CP may then be due to the direct
disruption of F-actin, which blocks EGFR early signaling.
The effect of 4-MU seemed slightly different, as 4-MU
impaired both filopodial and CDC42 activation. This result
suggests that HAS activity is necessary for F-actin stability,
CDC42 activation, normal EGFR signaling, and epidermal
homeostasis.
HAFi, an option for counteracting the adverse effects of CP on
the skin
HAFi acts as a positive regulator of epidermal homeostasis by
antagonizing the atrophogenic activity of CP (Figure 1). This
antagonism was reflected by their opposite effects in vitro on
filopodia. As shown in Figure 3, HAFi activates filopodia by
probably binding to CD44 that is also detected in filopodia.
This interaction seems to activate CDC42, but not EGFR
(Figure 3c). In mice, if HAFi only partially restored HA and
CD44 staining, F-actin network, in contrast, appeared to be
fully restored (Figure 1c and Supplementary Figure S3 online).
In addition, the dotted pattern of F-actin between cells in
Figure 1c may correspond with in vivo filopodia. We therefore
Control
+
H
A
F
I
Fr
eq
ue
nc
y
Si
ze
 μ
M
200 nM 2 μM 10 μM
200 nM 2 μM 10 μM 200 nM 2 μM 10 μM
μM μM
CP
200 μM
CP
2 μM
CP
10 μM
CP 1 H P<0.05
P<0.05
P<0.05 P<0.05 P<0.05 P<0.05 P<0.05
P<0.05 P<0.05
8 H
Control
4-MU 1 mM
4-MU
1 mM
+HAFiC 4-MU
1 mM
+HAFiC 4-MU
1 mM
+HAFiC 4-MU
1 mM
+HAFiC
4-MU 1 mM + HAFiControl
HABP HABP
CD44v3 CD44v3
Merge
Filopodia per cell (1H) Filopodia size (1H) Filopodia per cell (8H) Filopodia size (8H)
Merge
CP CP + HAFI 100 μg ml–1
HAFi 100 μg ml–1
7
+
H
AF
i
+
H
AF
i
+
+
H
AF
i
+
H
AF
i
+
H
AF
i
+
H
AF
i
+
H
AF
i
+
H
AF
i
+
H
AF
i
+
H
AF
i
+
H
AF
i
+
H
AF
i
6
5
*
*
*
*
*
*
*
*
*
*
*
*
*
* *
*
*
*
*
*
*
4
3
2
1
0
7
6
5
4
3
2
1
0
a
b
c
70
80
90
Control HAFi CP
200 nM
CP
2 μM
CP
10 μM
Control HAFi
60
50
40
30
20
80 7
6
5
4
3
2
1
0
60
40
20
0
80
60
40
20
0
10
0
70
80
90
60
50
40
30
20
10
0
μM μM
H
A
F
i
+
H
A
F
i
+
H
A
F
i
+
H
A
F
i
7
6
5
4
3
2
1
0
P<0.05 P<0.05
P<0.05
Figure 4. The intermediate-sized hyaluronic acid fragments (HAFi) prevent the inhibition of filopodia induced by clobetasol propionate (CP) and
4-methylumbelliferone (4-MU). (a) a-Phalloidin-rhodamine staining of F-actin (red) with a counterstaining of DNA with 4’,6-diamidino-2-phenylindole
dihydrochloride (DAPI; blue) of keratinocytes exposed to CP with or without HAFi for 1 hour, and a quantification of filopodial size and frequency based on 10
keratinocytes exposed to CP for 1 or 8 hours. (b) CD44v3 (red) and HA (green) stainings. (c) a-Phalloidin-rhodamine staining of F-actin (red) with a counterstaining
of DNA with DAPI (blue) of keratinocytes exposed to 4-MU with or without HAFi for 1 hour and a quantification of filopodial size and frequency. Scale
bar¼ 24mm. The P-values were calculated with the analysis of variance (ANOVA) method followed by Newman–Keuls post hoc test to calculate P-values between
each group; * indicates P-values o0.05 compared with control.
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believe that the anti-atrophic activity of HAFi in vivo depends
on the activation of CDC42 and filopodia (Figure 3). By
preserving the filopodia, we assume that HAFi also preserves
HA secretion, CD44–HA interaction (Figure 4), and physiolo-
gical responsiveness of keratinocytes to EGFs.
Finally, the molecular size of HAF appeared essential for
its biological activity in the epidermis. According to our
in vivo and in vitro models, the suitable size for such a
biological activity ranges between 50 and 400 kDa. The size
of endogenous HA is usually higher. Nevertheless, several
data suggested that HAS3, reported to synthesize HA
polymers smaller than HAS2 (Itano and Kimata, 2002),
may be the main variant expressed in the epidermis (Sayo
et al., 2002; Mack et al., 2011; Barnes et al., 2012). HAFi
may then just correspond to the size of endogenous HA in
the epidermis.
Hyalurosome, a communication platform between ECM and
keratinocytes, as a target of corticosteroids
A molecular platform that we called hyalurosome (Barnes
et al., 2010), located in filopodia involved in HA secretion and
EGFR signaling, and anchored on F-actin fibers, seems to
constitute an interface between the cellular signaling, cellular
cytoskeleton, and the ECM (Figure 6). This communication
platform between ECM and F-actin may also affect intercel-
lular junctions that are anchored on F-actin (Niessen, 2007),
and finally the overall epidermal homeostasis. Our results
suggest that the hyalurosome is the target of corticosteroids
and may be a target to prevent the corticosteroid-induced
epidermal atrophy.
MATERIALS AND METHODS
Mouse treatments
SKH1 hairless mice were treated by a topical application (100 ml)
of HAF 2% and/or CP 0.05% dissolved in water/ethanol/
polyethylene-glycol solvent (60%/20%/20%). In the short treat-
ment protocol (6 days), animals were treated with solvent (control),
CP 0.05% or HAF 2% or HAF 2%þCP 0.05%. In the long
treatment protocol (18 days), CP 0.05% or HAF 2% was applied
alternatively in the morning and in the evening every day. Mice
were killed and their dorsal skin was fixed in 3% buffered
formaldehyde. Epidermal thickness was measured using the ImageJ
software (NIH, Bethesda, MD).
HAF
HAF of intermediary size (HAFi) has a molecular size range
between 50 and 400 kDa, as described in our previous report
(Kaya et al., 2006). HAF of small size (HAFs) was purchased
from Gedeon-Richter (Budapest, Hungary) and had an average
molecular size of 11 kDa. HAF of large size (HAFl) with an average
molecular size of 1,149 kDa was purchased from Contipro (Dolni
Dobrouc, Czech Republic).
Immunohistochemical stainings
Skin sections from mouse skins were either cryoconserved by
including in Tissue-Tek OCT compound, Sakura Finetek Europe,
Alphen aan den Rijn, The Netherlands, or dehydrated and embedded
in paraffin. Ki67 and CD44 immunostainings were performed on
paraffin-embedded sections. Sections were rehydrated, antigens were
unmasked by boiling sections in 10 mM citrate buffer, and then
stained with their respective antibodies (anti-Ki67 antibody: M7249,
clone TEC-3 from Dako, Glostrup, Denmark; biotinylated anti-CD44
antibody: KM201, 212-JM-238 from ImmunoK, AMS Biotechnology,
Oxon, UK). An anti-rat biotinylated antibody was used as secondary
antibody to detect Ki67. HA was stained using a biotinylated HA-
binding protein (400763, Seikagaku Biobusiness, Tokyo, Japan).
Sections were then incubated with a ready-to-use streptavidin/
horseradish peroxidase solution (DAKO) and revealed with DAB
(3,39-diaminobenzidine; Sigma, St Louis, MD). F-actin, keratin 1
(AF109; COVANCE, Neryville, CA), and filaggrin (PRB-417P;
COVANCE) staining was performed on cryosections fixed with
formaldehyde. F-actin staining was done after phosphate-buffered
saline/1% Triton permeabilization using a-phalloidin-tetramethylr-
hodamine B isothiocyanate (SC 301530; Santa-Cruz Biotechnology,
Santa-Cruz, CA). DNA was counterstained using DAPI (4’,6-diami-
dino-2-phenylindole dihydrochloride). Images were acquired with
a bright field and epifluorescence microscope (Avio vert 200,
AxioCam HRc; Carl Zeiss, Oberkochen, Germany). a-Phalloidin
staining was acquired with a LSM510META confocal microscope
(Carl Zeiss).
In vitro HA quantification
HA concentration in the cell supernatant was measured from
immortalized human keratinocytes (Steenbergen et al., 1996) plated
on 96-well plates with a final cell density of B20–30% with
keratinocyte serum-free medium. The next day, the culture medium
was replaced by fresh medium supplemented with CP. Supernatants
were collected 20 hours later. HA content was assessed in the
supernatants using the ELISA hyaluronic acid test kit (Corgenix,
Broomfield, CO). For HA analysis in the supernatant of
keratinocytes exposed for 24 hours to HAFi, HAFs, or HAFl at
100mg ml 1, cells were rinsed three times with phosphate-buffered
saline and incubated overnight in fresh serum-free medium.
Supernatants were collected 20 hours later.
Keratinocyte treatments
Keratinocytes, immortalized via transfection with papillomavirus
(Steenbergen et al., 1996), were cultured in normal keratinocyte
serum-free medium (Invitrogen, Carlsbad, CA) supplemented with
bovine pituitary extract and EGF (5 ng ml 1), or in a medium lacking
EGF supplemented with bovine pituitary extract only. CP, CD, and
4-MU were purchased from Sigma-Aldrich (St Louis, MO).
Cell stainings
Glass coverslips with cells were rinsed once with phosphate-buffered
saline and fixed for 10 minutes in a buffered 4% paraformaldehyde
solution. CD44v3 staining was performed directly using a CD44v3-
specific antibody (BMS144; Bender MedSytems, Gmbh, Vienna,
Austria). HA was stained using biotinylated HA-binding protein.
Anti-rabbit and anti-mouse IgG antibodies conjugated with Alexa
Fluor fluorescent dyes and FITC-conjugated streptavidin (Molecular
Probes, Carlsbad, CA) were used as secondary antibodies. F-actin was
stained after treatment in phosphate-buffered saline/0.1% Triton and
incubation with fluorescent a-phalloidin, G-actin with deoxyribonu-
clease I, and Alexa Fluor 488 conjugate (Molecular Probes, Invitro-
gen, Camarillo, CA).
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Filopodia/EGFR induction assay
Keratinocytes were seeded on glass coverslips (15% of confluence in
24-well plates) in serum-free medium containing or lacking EGF
according to the experiment. The next day, cells were exposed for
1 hour to HAFi, HAFs, HAFl (100mg ml 1), CP (10mM), 4-MU (1 mM),
or HB-EGF (5 ng ml 1, recombinant human HB-EGF, 259-HE; R&D
Systems, Minneapolis, MN), before being fixed in 3% paraformalde-
hyde buffered solution or lysed for collecting protein extracts. Cells
were stained with a-phalloidin. Filopodial size and frequency were
analyzed using the ImageJ software (NIH). Western blot analyses were
performed using the anti-phospho-EGFR (Tyr 1068; Invitrogen).
CDC42 activation assay
Cells were plated at 15% confluence in keratinocyte serum-free
medium lacking EGF. The next day, the culture medium was
supplemented with HAFi, HB-EGF, CPþHB-EGF, or 4-MUþHB-
EGF. Cells were collected 6 minutes later according to the
procedures of the CDC42 G-LISAM Cdc42 activation kit (Cytoskele-
ton, Denver, CO).
Quantitative PCR
RNA was prepared by using Trizol reagent (Invitrogen). A chloroform
extraction was done and the aqueous phase was collected. RNA
was precipitated with isopropanol, washed with ethanol 75%,
and resuspended in water. Taqman assays were purchased from
Applied Biosystems (Carlsbad, CA) (hyaluronan synthase 3¼
Hs00193436_m1, hyaluronan synthase 2¼Hs00193435_m1, CD44
molecule (Indian blood group)¼Hs00174139_m1, heparin-binding
EGF-like growth factor¼Hs00181813_m1, hyalurono-glucosamini-
dase¼Hs00186839_m1). The efficiency of each design was tested
with serial dilutions of complementary DNA. PCR reactions (10ml
volume) contained diluted complementary DNA, 2 TaqMan Master
Mix (Applied Biosystems), and 300 nM of forward and reverse primers.
PCR was performed using a SDS 7900 HT instrument (Applied
Biosystems) with the following parameters: 40 cycles of 95 1C for
10 minutes, 95 1C for 15 seconds, and 60 1C for 1 minute. Each
reaction was performed in three replicates on 384-well plates. Raw
Ct values obtained with SDS 2.2 (Applied Biosystems) were imported
to Excel. Values normalized to those of EEF1A1 gene expression.
TUNEL assay
TUNEL assays were performed for paraffin-embedded tissues using
DeadEnd Fluorometric TUNEL System (Promega, Madison, WI)
according to the manufacturer’s instructions.
Statistical analysis
Statistical analysis was performed using the GraphPad Prism
software (La Jolla, CA).
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